<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03956966</url>
  </required_header>
  <id_info>
    <org_study_id>88-11/2018</org_study_id>
    <nct_id>NCT03956966</nct_id>
  </id_info>
  <brief_title>Quadratus Luborum Block Using Bupivacaine Versus Bupivacaine-Dexamethasone in Laparoscopic Cholecystectomy</brief_title>
  <official_title>Ultrasound-guided Quadratus Luborum Block Using Bupivacaine Versus Bupivacaine-Dexamethasone for Postoperative Analgesia in Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study was to compare the effectiveness of transmuscular Quadratus
      Lumborum block using Bupivacaine versus Bupivacaine- Dexamethasone in providing analgesia in
      patients undergoing laparoscopic cholecystectomy.

      Because postoperative pain after laparoscopic surgery is complex, specialists suggest that
      effective analgesic treatment should be a multimodal support. Quadratus lumborum block (QLB)
      is a new abdominal truncal block for controlling somatic pain in both the upper and lower
      abdomen. Dexamethasone, through its anti-inflammatory and blocking effects on neural
      discharge, and nociceptor C fibers transmission could be used as a local anesthetic adjuvant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients were randomly allocated into three groups each contains (30) patient. Control
      group (C) received bilateral ultrasound guided quadratus lumborum block using (20 ml 0.9%
      normal saline + 1mL 0.9% normal saline) in each side ,Bupivacaine group (B) received
      bilateral quadratus lumborum block using (20 ml Bupivacaine hydrochloride 0.25% + 1mL 0.9%
      normal saline) in each side and Dexamethasone-Bupivacaine group (D) received bilateral
      quadratus lumborum block using (20 ml Bupivacaine hydrochloride 0.25% + 1 mL dexamethasone
      &quot;4mg&quot;) in each side.

      The following variables: heart Rate, mean arterial Blood Pressure, peripheral oxygen
      saturation, visual analogue pain scale , time to first analgesic request, total Analgesic
      requirement in the first 24 hours, patient satisfaction and complications were Recorded and
      compared between groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2018</start_date>
  <completion_date type="Anticipated">February 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized, double blind</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time for first request to rescue analgesia</measure>
    <time_frame>24 hours</time_frame>
    <description>Time for the first request to rescue analgesia (in minutes)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative Nalbuphine</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Cumulative postoperative Nalbuphine consumption (total dose given in milligrams)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraoperative fentanyl</measure>
    <time_frame>For 4 hours after start of anaesthesia</time_frame>
    <description>Cumulative intraoperative fentanyl consumption (total dose given in micrograms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain severity will be assessed using VAPS</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>The severity of postoperative pain will be measured and recorded by using the visual analogue scale (VAPS) for pain, where 0 is equal to no pain and 10 indicates the worst possible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effects</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>Incidence of postoperative nausea and vomiting</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Post Operative Pain</condition>
  <arm_group>
    <arm_group_label>saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>bilateral quadratus lumborum block using 0.9% normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bilateral quadratus lumborum block using Bupivacaine hydrochloride 0.25%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine and dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bilateral quadratus lumborum block using Bupivacaine hydrochloride 0.25% and dexamethasone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TQL block with saline</intervention_name>
    <description>drug: saline 21 ml 0.9% normal saline administered on each side as bilateral TQL blocks Drug: fentanyl With induction of general anaesthesia, fentanyl (1 microgram.kg) will be given. Intraoperatively, fentanyl boluses (0.5 microgram.kg) will be given in case of increase in intraoperative mean arterial blood pressure or heart rate of more than 20% of baseline for longer than 5 minutes.
Drug: Paracetamol Paracetamol infusion (15 mg.kg) will be given by intravenous infusion after induction of general anesthesia. Postoperatively, 1 g of paracetamol will be given by intravenous infusion to all cases every 8 hours.
Drug: Ketorolac analgesia In PACU Ketorolac 30 mg ampoule will be given by intravenous infusion to all cases Drug: Nalbuphine Nalbuphine boluses 0.1 mg. /kg will be given as rescue analgesia if VAS is more than3.
Device: ultrasound-guided nerve block Transmuscular quadratus lumborum block, ultrasound-guided</description>
    <arm_group_label>saline</arm_group_label>
    <other_name>C Group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TQL block with Bupivacaine</intervention_name>
    <description>Drug: saline
1mL 0.9% normal saline administered on each side as bilateral TQL blocks drug: Bupivacaine 20 ml Bupivacaine hydrochloride 0.25% administered on each side as bilateral TQL blocks Drug: fentanyl With induction of general anaesthesia, fentanyl (1 microgram.kg) will be given. Intraoperatively, fentanyl boluses (0.5 microgram.kg) will be given in case of increase in intraoperative mean arterial blood pressure or heart rate of more than 20% of baseline for longer than 5 minutes.
Drug: Paracetamol 15 mg.kg will be given by intravenous infusion after induction of general anesthesia. Postoperatively, 1 g of paracetamol will be given to all cases every 8 hours.
Drug: Ketorolac In PACU Ketorolac 30 mg ampoule will be given by intravenous infusion to all cases Drug: Nalbuphine Nalbuphine boluses 0.1 mg. /kg will be given as rescue analgesia if VAS is more than 3.
Device: ultrasound-guided nerve block Transmuscular quadratus lumborum block</description>
    <arm_group_label>Bupivacaine</arm_group_label>
    <other_name>B Group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TQL block with Bupivacaine and dexamethasone</intervention_name>
    <description>Drug: dexamethasone
1 mL dexamethasone &quot;4mg&quot; administered on each side as bilateral TQL blocks drug: Bupivacaine 20 ml Bupivacaine hydrochloride 0.25% administered on each side as bilateral TQL blocks Drug: fentanyl With induction of general anaesthesia, fentanyl (1 microgram.kg) will be given. Intraoperatively, fentanyl boluses (0.5 microgram.kg) will be given in case of increase in MBP or HR of more than 20% of baseline for longer than 5 minutes.
Drug: Paracetamol Paracetamol infusion (15 mg.kg) will be given by intravenous infusion after induction of general anesthesia. Postoperatively, 1 g of paracetamol will be given by intravenous infusion to all cases every 8 hours.
Drug: Ketorolac In PACU Ketorolac 30 mg ampoule will be given by intravenous infusion to all cases Drug: Nalbuphine Nalbuphine boluses 0.1 mg. /kg will be given as rescue analgesia if VAS is more than 3.
Device: ultrasound-guided nerve block Transmuscular quadratus lumborum block</description>
    <arm_group_label>Bupivacaine and dexamethasone</arm_group_label>
    <other_name>D Group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Physical Status I or II

          -  Elective laparoscopic Cholecystectomy

        Exclusion Criteria:

          -  Patient refusal.

          -  Hematological diseases

          -  Bleeding disorders.

          -  Coagulation abnormality.

          -  Psychiatric diseases.

          -  Local skin infection

          -  Sepsis at site of the block.

          -  Known intolerance to the study drugs.

          -  Body Mass Index &gt; 40 Kg/m2.

          -  Emergency laparoscopic cholecystectomy

          -  If laparoscopic procedure converted to open.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haidy S Mansour, MD</last_name>
    <role>Study Director</role>
    <affiliation>assistant professor of Anesthesia and Surgical Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Haidy S Mansour, MD</last_name>
    <phone>01221802324</phone>
    <phone_ext>+2</phone_ext>
    <email>haidy_mourad@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohmed S Abdelrahman, Dr</last_name>
    <phone>01000344985</phone>
    <phone_ext>+2</phone_ext>
    <email>dr.ma55.ma@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Minya University</name>
      <address>
        <city>Minya</city>
        <zip>61519</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>haidy S Mansour, MD</last_name>
      <phone>01221802324</phone>
      <phone_ext>+2</phone_ext>
      <email>haidy_mourad@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>mohamed A abdelrahman, Dr</last_name>
      <phone>01000344985</phone>
      <phone_ext>+2</phone_ext>
      <email>dr.ma55.ma@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>May 8, 2019</study_first_submitted>
  <study_first_submitted_qc>May 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2019</study_first_posted>
  <last_update_submitted>January 30, 2020</last_update_submitted>
  <last_update_submitted_qc>January 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>haidy salah mansour</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <keyword>Quadratus Lumborum Block</keyword>
  <keyword>Laparoscopic Cholecystectomy</keyword>
  <keyword>dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

